Published: Vol 10, Iss 9, May 5, 2020 DOI: 10.21769/BioProtoc.3602 Views: 5644
Reviewed by: Meenal SinhaJason A. NeidlemanAnonymous reviewer(s)
Protocol Collections
Comprehensive collections of detailed, peer-reviewed protocols focusing on specific topics
Related protocols
PBMC-Humanized Mouse Model for Multiple Sclerosis: Studying Immune Changes and CNS Involvement
Anastasia Dagkonaki [...] Lesley Probert
May 20, 2025 1650 Views
Proliferation Assay Using Cryopreserved Porcine Peripheral Mononuclear Cells Stimulated With Concanavalin A and Analyzed With FCS ExpressTM 7.18 Software
Marlene Bravo-Parra [...] Luis G. Giménez-Lirola
Jun 5, 2025 951 Views
Isolation and Ex Vivo Testing of CD8+ T-Cell Division and Activation Using Mouse Splenocytes
Melissa Dolan [...] John M.L. Ebos
Aug 20, 2025 1096 Views
Abstract
Generation of antibodies is crucial for establishing enduring protection from invading pathogens, as well as for maintaining homeostasis with commensal bacteria at mucosal surfaces. Chronic exposure to microbiota- and dietary- derived antigens results in continuous production of antibody producing cells within the Peyer’s patch germinal center structures. Recently, we have shown that B cells responding to gut-derived antigens colonize the subepithelial dome (SED) in Peyer’s patches and rapidly proliferate independently of their relative BCR affinity. To evaluate B cell proliferation within different niches in Peyer’s patches, we applied in vivo EdU incorporation assay as described in this protocol.
Background
Long-lived antibody producing cells, also known as plasmablasts or plasma cells (PCs) primarily originate from germinal centers (GCs), microanatomical sites that form within lymphoid organs following infection or immunization. Entry into the GC reaction involves affinity-based competition of B cells, each expressing an antigen-specific B cell receptor (BCR) with a given affinity and specificity towards the antigen. Upon antigen encounter, B cell activation takes place, which is accompanied by extensive clonal expansion through rapid proliferation. Peyer’s patches (PPs) are lymphoid organs located along the small intestine and are the main site where B cells class switch their immunoglobulins to IgA. The subepithelial dome (SED) is a small niche within the PP wherein immune cells, including B cells, interact with gut-derived antigens. During pre-GC events in PPs, B cells bearing high affinity BCRs do not show preferential advantage in colonization of the SED and formation of PCs, indicating that affinity-based competition does not take place at this site (Biram et al., 2019). Nonetheless, only high affinity clones progress into the GC structures and enter the germinal center reaction. Massive proliferation is a major aspect of the GC reaction in peripheral lymph nodes, spleen and PPs (Victora and Nussenzweig, 2012). During the GC response, B cells undergo iterative cycles of migration between the dark zone (DZ), where they proliferate and mutate their antibody-encoding genes and the light zone (LZ), where the high affinity varaiants are selected by T follicular helper (Tfh) cells for preferential expansion and differentiation into plasma cells. B cells in the GC rapidly divide, and the magnitude of this proliferation is proportional to the strength of T cell help (Gitlin, Shulman and Nussenzweig, 2014). Although B cell proliferation can be induced in vitro by LPS and anti-IgM stimulation, analysis of GC B cell proliferation in culture is currently not possible. In particular, analysis of B cell proliferation in specialized immunological niches such as the SED, can be only examined in vivo.
There are various techniques to measure cell proliferation, which are based on the detection of DNA synthesis, cellular metabolism or proliferation-associated proteins. Cellular metabolism markers such as MTT, XTT and WST-1 assays provide an indirect measurement of cell proliferation and can be inaccurate or in some cases toxic to cells (Liu et al., 1997; Huang et al., 2004). The use of proliferation proteins is a more common and widely used technique and includes staining for Ki67, PCNA and MCM-2 proteins (Bologna-Molina et al., 2013; Carreón-Burciaga et al., 2015). DNA synthesis-based techniques including BrdU, EdU, IdU and CIdU rely on the incorporation of these nucleoside analogs into newly formed DNA strands. As for EdU, the nucleoside incorporation is detected by a click reaction that involves a copper-catalyzed azide-alkyne cycloaddition. DNA replication occurs during S-phase and at this stage, nucleosides are being integrated into the newly formed DNA. Cell cycle progression towards G2/M-phase involves an increase in DNA content. The combination of EdU administration with DNA content staining, which discriminates G1, S and G2/M cells, allows the analysis of proliferation in the different cell-cycle stages. Unlike proliferation-associated protein measurement, DNA synthesis-based measurement, which involves injection of nucleosides into mice, can capture the dynamics of proliferation according to the time allowed for the nucleoside to incorporate into the DNA (Ouadah et al., 2019). In addition, combination of more than one analog, followed by analog-specific detection may provide information on cell populations at different cell cycle stages and on the rate of transition between the stages. Such a method was implemented to study how the magnitude of T cell help affects the speed of the cell cycle within the GC response (Gitlin et al., 2014). Therefore, EdU and other analogs are the preferred method for quantification of proliferating cells within the germinal center. Here, we provide details for EdU incorporation measurement by flow cytometry of B cells in different compartments within the gut associated lymphoid organs. This protocol can be easily adapted to analyze cell proliferation in other experimental systems.
Materials and Reagents
Equipment
Software
Procedure
Notes: Buffers should be prepared fresh on the day of the experiment:
Data analysis
Cells that incorporated the EdU are detected by flow cytometry with the indicated fluorophore. Gate on your population of interest and from this population gate on the EdU+ cells in a histogram or on a dot plot. EdU+ cells in the germinal center are often a distinct population (see Figure 1 below) but in some cases may appear as a tail of the population, depending on the detection efficiency. Naïve B cells are used as a negative control, where no proliferation takes place. For 2.5 h incubation with EdU, the normal range for GC EdU+ cell population is 20-30%. A total of 1.5 million events were acquired per sample.
Figure 1. EdU distribution in naïve, GC and SED PP B cells
Notes
This protocol provides details for EdU detection using a commercial kit by Invitrogen, Thermo Fisher Scientific and was therefore adapted from the kit manual and adjusted to our experimental setup. Please note that two flow cytometry kits are available: Click-iTTM EdU Flow Cytometry Assay Kit and Click-iTTM Plus EdU Flow Cytometry Assay Kit. This protocol is reproducible only with the Click-iTTM Plus kit due to its compatibility with the fluorophores used in the study associated with this protocol.
Recipes
Acknowledgments
Z.S. is supported by the European Research Council (grant No. 677713), Human Frontiers of Science Program (grant No. CDA-00023/2016), Israel Science Foundation (grant No. 1090/18), Azrieli Foundation, Rising Tide Foundation and the Morris Kahn Institute for Human Immunology. Z.S. is a member in the European Molecular Biology Organization Young Investigator Program and is supported by grants from The Benoziyo Endowment Fund for the Advancement of Science, The Sir Charles Clore Research Prize, Comisaroff Family Trust, Irma & Jacques Ber-Lehmsdorf Foundation, Gerald O. Mann Charitable Foundation and David M. Polen Charitable Trust.
This protocol provides details regarding EdU in vivo proliferation assay as previously described (Biram et al., 2019).
Competing interests
The author declare no competing interests.
Ethics
All experimental procedures have been approved by the Weizmann Institute Animal Care and Use Committee (IACUC) and followed all relevant ethical regulations, IACUC number 00960118-4.
References
Article Information
Copyright
© 2020 The Authors; exclusive licensee Bio-protocol LLC.
How to cite
Biram, A. and Shulman, Z. (2020). Evaluation of B Cell Proliferation in vivo by EdU Incorporation Assay. Bio-protocol 10(9): e3602. DOI: 10.21769/BioProtoc.3602.
Category
Immunology > Immune cell function > Lymphocyte
Immunology > Animal model > Mouse
Cell Biology > Cell-based analysis > Flow cytometry
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.
Share
Bluesky
X
Copy link